Report Feature
The future of the diabetes device market looks promising with opportunities in the hospitals, homecare, and diagnostic centers. The global diabetes device market is expected to grow with a CAGR of 12% to 14% from 2023 to 2028. The major drivers for this market are increasing prevalence of obesity and diabetes, growing health consciousness and awareness regarding diabetes, development of advanced diabetes devices, and increasing adoption of insulin delivery devices.
The study includes a forecast for the global diabetes device market by product type, distribution channel, end use industry, and region, as follows:
Diabetes Device Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2028]:
-
Blood Glucose Monitoring Devices
- Self-Monitoring Devices
- Continuous Glucose Monitoring Devices
-
Insulin Delivery Devices
- Pens
- Pumps
- Jet Injectors
- Syringes
- Hospital pharmacies
- Retail Pharmacies
- Diabetes Clinics/Centers
- Online Pharmacies
- Others
- Hospitals
- Homecare
- Diagnostic Centers
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies diabetes device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the surgical lasers’ companies profiled in this report include.
- Abbott Laboratories
- Arkray
- B. Braun Melsungen AG
- Dexcom
- F. Hoffmann-La Roche AG
- Medtronic PLC
- Sinocare
- Nova Biomedical
- Sanofi
- Novo Nordisk
- Lucintel forecasts that insulin delivery devices will remain the fastest growing segment over the forecast period due to unhealthy lifestyles, technological advancement in insulin delivery devices like insulin pens, insulin pumps, jet injectors, and other devices, and more people are using insulin patches, and smart insulin pumps to self-manage their diabetes.
- Hospital is expected to remain the largest segment due to growing number of hospitalization cases of diabetic patients and the advancements in technology have increased the usage of insulin pumps and diabetes care in hospitals and clinics.
- North America will remain the largest region due to large number of diabetic population and favorable reimbursement policies, high per capita income, increasing healthcare spending, and increasing prevalence of obesity and high cost of treatment.
- Market Size Estimates: Diabetes devices market size estimation in terms of value ($B)
- Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Diabetes devices market size by various segments, such as by product type, distribution channel, end use industry, and region.
- Regional Analysis: Diabetes devices market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different by product type, distribution channel, end use industry, and regions for the diabetes device market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the diabetes device market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q1. What is the diabetes device market size?
Answer: The global diabetes device market is expected to reach an estimated $xx billion by 2028.
Q2. What is the growth forecast for diabetes device market?
Answer: The global diabetes device market is expected to grow with a CAGR of 12% to 14% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the diabetes device market?
Answer: The major drivers for this market are increasing prevalence of obesity and diabetes, growing health consciousness and awareness regarding diabetes, development of advanced diabetes devices, and increasing adoption of insulin delivery devices.
Q4. What are the major segments for diabetes device market?
Answer: The future of the diabetes device market looks promising with opportunities in the hospitals, homecare, and diagnostic centers.
Q5. Who is the key diabetes device companies?
Answer: Some of the key diabetes device’s companies are as follows:
- Abbott Laboratories
- Arkray
- B. Braun Melsungen AG
- Dexcom
- F. Hoffmann-La Roche AG
- Medtronic PLC
- Sinocare
- Nova Biomedical
- Sanofi
- Novo Nordisk
Answer: Lucintel forecasts that insulin delivery devices will remain the fastest growing segment over the forecast period due to unhealthy lifestyles, technological advancement in insulin delivery devices like insulin pens, insulin pumps, jet injectors, and other devices, and more people are using insulin patches, and smart insulin pumps to self-manage their diabetes.
Q7. In diabetes device market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to large number of diabetic population and favorable reimbursement policies, high per capita income, increasing healthcare spending, and increasing prevalence of obesity and high cost of treatment.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising, high-growth opportunities for the diabetes device market by product type (blood glucose monitoring devices and insulin delivery devices), distribution channel (hospital pharmacies, retail pharmacies, diabetes clinics/centers, online pharmacies, and others), end use industry (hospitals, homecare, and diagnostic centers) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- • Which segments will grow at a faster pace and why?
- • Which region will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- • What are the business risks and competitive threats in this market?
- • What are the emerging trends in this market and the reasons behind them?
- • What are some of the changing demands of customers in the market?
- • What are the new developments in the market? Which companies are leading these developments?
- • Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- • What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- • What M&A activity has occurred in the last 5 years and what has its impact been on the industry? For any questions related to diabetes device market or related diabetes device companies, diabetes device market size, diabetes device market share, diabetes device analysis, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.